A new drug shows significant promise in reducing hot flashes in menopausal women, according to a study published in the UK’s medical journal, The Lancet.
A hot flash is a sudden rise in temperature accompanied by sweating, feeling flush and turning red. Some women experience an increased heart rate as well. Hot flashes are often associated with women in menopause.
During the trial period, the drug, known as MLE4901, was shown to reduce hot flashes in women by almost 75 percent. The drug blocks the body chemical, neurokinin B. Neurokinin B, also known as NKB, has been known to cause hot flashes in laboratory rats, as well as women in other research studies. By blocking the body from producing this chemical, the drug will block hot flashes.